Marker Therapeutics Inc (MRKR)

[apostrophe]

So, they're issuing/registering 50M or so new shares to cover all the warrants which if exercised all at once would depress the share price considerably but you're saying that probably only enough will be exercised to cover minimal operating expenses of about $6M this year, which if spaced out, would have a more minimal impact on pps?